Tri-lo-mili Kit
Product Images NDC 71205-746

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tri-lo-mili (NDC 71205-746). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Norgestimate Fig1)

Instructional diagram showing the dose schedule for Tri-Lo-Mili oral tablets. The diagram displays four rows labeled Week 1 to Week 4, each with seven circles representing days Sunday through Saturday. The circles are color-coded from white/off-white in Week 1, pale blue in Week 2, blue in Week 3, to green in Week 4, illustrating the progression of tablet colors for the 28-day dosing kit containing norgestimate and ethinyl estradiol tablets.*

FDA Label Image

Figure (Norgestimate Fig2)

An instructional diagram for the Tri-Lo-Mili kit showing how to place a day label strip on the blister pack. The pack displays four rows of circular tablets, each row with distinct color coding (white to off white, pale blue to bluish white, blue to light blue, and green) representing different weeks and dosages of norgestimate and ethinyl estradiol tablets. A hand is shown positioning the day label above the pack for correct day tracking.*

FDA Label Image

Figure (Norgestimate Fig3)

A forest plot titled 'Risk of Breast Cancer with Combined Oral Contraceptive Use' showing effect estimates (OR/RR) from multiple studies between 2002 and 2017. Studies are listed on the left with point estimates and confidence intervals plotted on a horizontal axis ranging from -1.5 to 2.0, illustrating risk ratios with a vertical reference line at 1.0.*

FDA Label Image

Figure (Norgestimate Fig4)

An illustration depicting a comparison of pregnancy rates per 100 women per year associated with various birth control methods. The graphic features a vertical arrow labeled 'Fewer Pregnancies' at the top and 'More Pregnancies' at the bottom, with corresponding pregnancy rate ranges on the left. On the right, contraceptive methods are grouped by effectiveness, including implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, behavioral methods, and no birth control.*

FDA Label Image

Figure (Norgestimate Fig5)

An instructional diagram for the Tri-Lo-Mili kit showing a weekly dosage schedule. It displays four rows of circles labeled for each day of the week, with color coding from white/off white, pale blue/bluish white, blue/light blue, to green, indicating different weekly tablet colors and corresponding dosages for norgestimate and ethinyl estradiol tablets.*

FDA Label Image

Figure (Norgestimate Fig6)

An instructional diagram for the Tri-Lo-Mili oral contraceptive tablet kit. It shows a hand placing a peel-and-place day label strip on a 28-day pill card organized by weeks. The pill card contains four rows of circular tablets: white to off-white (Week 1), pale blue to bluish white (Week 2), blue to light blue (Week 3), and green (Week 4). Arrows indicate the sequence and day labeling to guide correct daily dosing.*

FDA Label Image

71205-746-28 (Norgestimate Fig7)

Label for Tri-Lo-Mili 0.18mg/0.025mg, a 28-day tablet kit from Proficient Rx LP. The label includes the NDC 71205-746-28, states RX only, and indicates manufacturing by Aurobindo Pharma Limited in Hyderabad, India. Storage instructions specify 20°-25°C, with warnings to keep medication out of reach of children.*

FDA Label Image

Chemical Structure (Norgestimate Str)

Chemical structure diagrams of the active ingredients Norgestimate and Ethinyl Estradiol, shown side by side with labeled molecular structures illustrating their steroid-based frameworks.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.